Xinxiang SLP Pharmaceutical Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 30 million on January 9, 2021. The transaction will include participation from returning investors Beijing SL Pharmaceutical Co., Ltd. (SZSE:002038) for CNY 21 million and Xinxiang Chemical Fiber Co., Ltd. (SZSE:000949) for CNY 9 million to retain their 70% and 30% stake in the company respectively. The capital of the company will increase from The transaction has been approved at the 16th interim meeting of the 7th board of directors and the 7th board of supervisors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.64 CNY | +0.47% | -2.70% | -15.21% |
Apr. 24 | Beijing SL Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023 | CI |
Apr. 23 | Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.21% | 1.22B | |
+29.82% | 682B | |
+30.35% | 586B | |
-3.75% | 364B | |
+17.73% | 327B | |
+3.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+7.37% | 165B |
- Stock Market
- Equities
- 002038 Stock
- News Beijing SL Pharmaceutical Co., Ltd.
- Xinxiang SLP Pharmaceutical Co., Ltd. announced that it expects to receive CNY 30 million in funding from Beijing SL Pharmaceutical Co., Ltd., Xinxiang Chemical Fiber Co., Ltd.